Quantifying the Impact of the COVID-19 Pandemic on Clinical Trial Enrollment Rates Over Time in 37 Countries

Kelsey McDonald,Kamal S. Saini, Mary Lu, Stefan Diaz Gaisenband, Cassandra Fletcher, Patrick McLeroth, Earl Seltzer

Research Square (Research Square)(2022)

引用 0|浏览0
暂无评分
摘要
Abstract The COVID-19 pandemic has had an unprecedented and disruptive impact on people’s health and lives worldwide. In addition to burdening people’s health in the short-term in the form of infection, illness, and mortality, there has been an enormous negative impact on clinical research. Clinical trials experienced challenges in ensuring patient safety and enrolling new patients throughout the pandemic. Here, we investigate and quantify the negative impact that the COVID-19 pandemic has industry-sponsored clinical trials, both in the United States and worldwide. We find a negative correlation between the severity of the COVID-19 pandemic and clinical trial enrollment rate, with the relationship being strongest during the first three months of the pandemic compared to the entire duration of the pandemic. This negative statistical relationship holds across therapeutic areas, across states in the US despite the heterogeneity of responses at the state-level, and across countries. This work has significant implications for the management of clinical trials worldwide in response to the fluctuating severity of COVID-19 moving forward, and for future pandemics.
更多
查看译文
关键词
clinical trial enrollment rates,clinical trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要